modelN01AB05

Diagram of N01AB05

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Trichloroethylene
ATC code:N01AB05
route:inhalation
compartments:2
dosage:450mg
volume of distribution:0.67L
clearance:1.4mL/min/kg
other parameters in model implementation

Trichloroethylene is a volatile chlorinated organic solvent that has been used historically as an inhalation anesthetic and analgesic agent but is now primarily employed in industrial applications as a degreasing solvent. Due to concerns about toxicity, carcinogenicity, and safer alternatives, medical use in anesthesia has been discontinued in most countries.

Pharmacokinetics

Pharmacokinetic parameters reported in healthy adult human volunteers following single inhalation exposure.

References

  1. Waters, EM, et al., & Huff, JE (1977). Trichloroethylene. I. An overview. Journal of toxicology and environmental health 2(3) 671–707. DOI:10.1080/15287397709529469 PUBMED:https://pubmed.ncbi.nlm.nih.gov/403297

  2. Rouhou, MC, et al., & Haddad, S (2015). In vivo effects of naproxen, salicylic acid, and valproic acid on the pharmacokinetics of trichloroethylene and metabolites in rats. Journal of toxicology and environmental health. Part A 78(11) 671–684. DOI:10.1080/15287394.2015.1020977 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26039745

  3. Sohn, MD, et al., & Blancato, JN (2004). Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. Journal of exposure analysis and environmental epidemiology 14(3) 204–213. DOI:10.1038/sj.jea.7500314 PUBMED:https://pubmed.ncbi.nlm.nih.gov/15141149

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)